North American Respiratory Drug Market Top Leading Players with Strategies and Forecast 2025
North American respiratory drug market was $18.0 billion in 2018 and is anticipated to grow at a substantial rate of 7.6% during the forecast period. The major factors that are contributing significantly to the market growth include rising air pollution, growing geriatric population, and high healthcare expenditure. The US and Canada are the major economies of North America. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of the respiratory drug market in North America. The US is the major market due to greater healthcare expenditure and a higher prevalence rate of respiratory diseases.
To Request a Sample of our Report on North
American Respiratory Drug Market: https://www.omrglobal.com/request-sample/north-american-respiratory-drug-market
The North American respiratory drug
market is segmented on the basis of route of administration, application, and
end-user. Based on the route of administration, the market is classified into
oral, injectable, and inhalable. Moreover, on the basis of application, the
market has been classified into asthma and COPD diseases. The asthma disease
application segment dominated the regional market in 2018 and is further
estimated to follow the same trend over the forecast period. This is mainly due
to the high prevalence of asthma in the economies of the region such as the US
and Canada. According to the Centers for Disease Control and Prevention (CDC)
2017, there are around 26 million asthmatics in the US, among which, nearly
18.9 million are adults and 7.1 million are children. In addition, based on the
end-user, homecare and hospitals and clinics have been analyzed.
(Get 15% Discount on Buying this Report)
A
full Report of North American Respiratory Drug Market is Available @ https://www.omrglobal.com/industry-reports/north-american-respiratory-drug-market
North American Respiratory
Drug Market Segmentation
By Route of Administration
·
Oral
·
Injectable
·
Inhalable
·
France Respiratory Drug Market by Application
·
Asthma
·
Chronic Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals and Clinics
Regional Analysis
·
US
·
Canada
Company Profiles
·
Air Liquide S.A.
·
Aradigm Corp.
·
AstraZeneca PLC
·
Baxter International Inc.
·
Boehringer Ingelheim International GmbH
·
F. Hoffmann-La Roche Ltd.
·
GlaxoSmithKline PLC
·
Merck & Co.
·
Novartis AG
·
Omron Healthcare Inc.
·
Pfizer Inc.
·
Pulmatrix Inc.
·
ResMed Corp.
·
Savara, Inc.
·
Sunovion Pharmaceuticals
·
Takeda Pharmaceutical Company Ltd.
·
Teva Pharmaceuticals Industries Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment